EUVIMEDEUVIMED entdecken
Open Access

Conformational dynamics and multimodal interaction of Paxillin with the focal adhesion targeting domain

Supriyo Bhattacharya iD, Yanan He, Yihong Chen, Atish Mohanty iD, Alexander Grishaev iD, Prakash Kulkarni, Ravi Salgia iD, John Orban iD

Science Advances · 2025

DOI: 10.1126/sciadv.adt9936 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Supriyo Bhattacharya und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA 91010-3000, USA. Hauptthemen laut MEDLINE: Paxillin, Focal Adhesions. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Paxillin (PXN) and focal adhesion kinase (FAK) are two major components of the focal adhesion complex, a multiprotein structure linking the intracellular cytoskeleton to the cell exterior. The interaction between the disordered amino-terminal domain of PXN and the carboxyl-terminal targeting domain of FAK (FAT) is necessary and sufficient for localizing FAK to focal adhesions. Furthermore, PXN serves as a platform for recruiting other proteins that together control the dynamic changes needed for cell migration and survival. Here, we show that the PXN N-domain undergoes significant compaction upon FAT binding, forming a 48-kilodalton multimodal complex with four major interconverting states. Although the complex is flexible, each state has unique sets of contacts involving disordered regions that are both highly represented in ensembles and conserved. PXN being a hub protein, the results provide a structural basis for understanding how shifts in the multistate equilibrium (e.g., through ligand binding and phosphorylation) may rewire cellular networks leading to phenotypic changes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PaxillinFocal AdhesionsProtein BindingProtein DomainsHumansProtein ConformationModels, MolecularFocal Adhesion Protein-Tyrosine KinasesPhosphorylationProtein Interaction Domains and Motifs

Substanzen

PaxillinFocal Adhesion Protein-Tyrosine Kinases

Autor:innen und Institutionen

  • Department of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA 91010-3000, USA.
  • University of Maryland Institute for Bioscience and Biotechnology Research, Rockville, MD 20850, USA.
  • Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010-3000, USA.
  • National Institute of Standards and Technology, Gaithersburg, MD 20850 USA.
  • Department of Systems Biology, City of Hope National Medical Center, Duarte, CA 91010-3000, USA.
  • Department of Chemistry and Biochemistry, University of Maryland, College Park, MD 20742, USA.

ORCID-Profile: Supriyo Bhattacharya, Atish Mohanty, Alexander Grishaev, Ravi Salgia, John Orban

Förderung

  • NCI NIH HHS

Zitieren

APA

Bhattacharya, S., He, Y., Chen, Y., Mohanty, A., Grishaev, A., Kulkarni, P., Salgia, R., & Orban, J. (2025). Conformational dynamics and multimodal interaction of Paxillin with the focal adhesion targeting domain. Science Advances. https://doi.org/10.1126/sciadv.adt9936

Vancouver

Bhattacharya S, He Y, Chen Y, Mohanty A, Grishaev A, Kulkarni P, et al. Conformational dynamics and multimodal interaction of Paxillin with the focal adhesion targeting domain. Science Advances. 2025. doi:10.1126/sciadv.adt9936

BibTeX
@article{Bhattacharya2025,
  author = {Bhattacharya, Supriyo and He, Yanan and Chen, Yihong and Mohanty, Atish and Grishaev, Alexander and Kulkarni, Prakash and Salgia, Ravi and Orban, John},
  title = {Conformational dynamics and multimodal interaction of Paxillin with the focal adhesion targeting domain},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.adt9936}
}
Kostenlos starten →